The report estimates that by the end of 2016, the chemotherapy/antibody category will hold a close to 40% market share in terms of revenue in the global Combination Antibody Therapy Market. Over the forecast period, the chemotherapy/antibody category is expected to grow at a CAGR of 7.8% in terms of value. By 2024, this market is anticipated to be worth close to US$ 35 billion.
The percentage of cancer-related mortality in the world has significantly increased in recent years. The World Health Organization (WHO) estimates that more than 8 million people die from cancer each year, and that over the next 20 years, there will likely be an increase in new cancer cases of nearly 70%.
Request for Free Sample Copy@ https://www.persistencemarketresearch.com/samples/11740
Chemotherapy is one of the specific treatments needed for each form of cancer. As a result, Combination Antibody Therapy Market is being driven by the rising incidence of cancer and the demand for chemotherapeutic drugs that can target cancer cells throughout the body.
The chemotherapy/antibody segment in the North America region was estimated to be valued at US$ 8,851.1 Mn by 2016 end and is expected to reach US$ 13,951.3 Mn by 2024. The chemotherapy/antibody segment in the North America combination antibody therapy market is expected to increase 1.6X in terms of revenue during the forecast period.
Get up to 20% discount on Full Report Purchase @ https://www.persistencemarketresearch.com/checkout/11740
While in Latin America and APAC regions the market share of the chemotherapy/antibody segment is more than 40%. In the APAC region, the chemotherapy/antibody segment was estimated to be valued at more than US$ 2,000 Mn by 2016 end and is expected to reach close to US$ 6000 Mn by 2024. The chemotherapy/antibody segment in the APAC combination antibody therapy market is expected to increase 2.1X in terms of revenue during the forecast period.
Request For Customization @ https://www.persistencemarketresearch.com/request-customization/11740
Market segmentation : Combination Antibody Therapy Market
Combination Antibody Therapy Market : By combination
- Chemotherapy/Antibody
- Antibody/Antibody
- Conjugated Antibodies
- Bispecific Antibodies
Combination Antibody Therapy Market : By application
Lung Cancer
Blood Cancer
- Lymphoma
- Leukemia
- Myeloma
Breast Cancer
Colorectal Cancer
Others
Combination Antibody Therapy Market : By end user
- Hospitals
- Cancer research institutes
- Clinics
- ASCs
Combination Antibody Therapy Market : By region
- North America
- Latin America
- Europe
- APAC
- MEA
Related Reports:
About Us:
About Us: Persistence Market Research’s Expertise in Life Sciences and Transformational Health, Our expert team of industry analysts comprising management graduates, medical professionals, engineers, and project managers provides insights on emerging therapy areas, diagnostic tools, medical devices and components, reimbursement and market access, biotechnology, and life science research products and services to equip decision-makers with sound inputs and strategic recommendations. Click here to learn more about how we zero in on the critical aspects of this industry.
Contact Us:
Persistence market research
Address – 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – [email protected]